AFM characterization of PDA chip surface. An atomic force microscopy (AFM, Dimension Icon, Bruker) was also employed to analyze the topography of the silicon surface with different concentrations of PDA. The AFM images were acquired in the tapping mode on a 5.0μm x 5.0μm scan area. The quantification method of the proteins encapsulated in PDA layer. The glass chip was modified with different concentrations of dopamine (16.5mM, 33mM, 66mM). And then HRP with different concentrations (5, 10, 50mg/ml) was mixed with dopamine for encapsulation and reacted for 1 hour. After wash slides with deionized water 2~3 times, dry in 37℃, the glass slides were assembled in FAST FRAM module（Sigma-Aldrich, United States.）, and then 100ul TMB substrate was added into each array and followed by shaking for 25 minutes in 25℃ in the dark. At last , 50ul TMB stop solution was added into each array, followed by shaking for about 5 minutes in 25℃ and the color of the solution changes from blue to yellow. The UV absorption of each array solution was recorded at 450 nm with microplate reader within 30 minutes.
amount of exosomes was added and the tube was rotated 360 degrees at 37℃ for 1 hours, subsequently the magnetic beads were separated and watered by PBS for three times. Finally, 1 mL 30μM Dio in ethanol was added into each tube and rotated at 37℃ for 30mins, then the magnetic beads-exosome complexes were separated and resuspended in PBS in proper concentration for the following flow cytometry (Beckman Coulter, United States, Gallios). Both PANC-01 and HPDE6-C7 groups had the controlled samples with goat anti-mouse IgG instead of anti-CD9/CD63/MIF/GPC-1. Analysis software was Flow Jo 7.6. The percentage of anti-CD9/CD63/MIF/GPC-1 positive exosomes was investigated in about 100000 events. Excitation wavelength was 484 nm, emission wavelength was 501 nm.
(c） (d) (e) 16.5mM, 33mM, 66mM) . (d) Raman spectrum of different concentration dopamine polymerized glass slide (the acquisition time of the three spectrum is 100s). e) UV−vis absorbance spectra of Au NPs (black line) and SERS Tags (red lines). f) SERS spectra of SERS Tag solution acquired under low laser power (0.05mW) and short acquisition time (10ms averaged for 100 times).
Obvious differences can be observed from the UV visible absorption spectra of gold nanoparticles and SERS tag. Gold nanoparticles (black line) have only one absorption peak at 521nm, while SERS tag appears two distinct absorption peaks at about 400nm and 500nm, which were attributed to the absorption peaks of the silver layer and the gold nanoparticles respectively. Except for the dopamine thickness, the thickness of Ag shell and the concentration of SERS reporter molecular also influence the signal and stability of SERS probe. Fig. S3 show the influence of the AgNO 3 amount on SERS intensity, it is found that the intensity of 1072cm -1 band significant increased when the AgNO 3 concentration increase from 0.004mM to 0.455mM, because that the thicker Ag shell could promote the Enhance Factor (EF) of NPs. When the AgNO 3 concentration exceeds 0.096mM, the Raman intensity dramatically dropped because of the aggregation of the NPs. The SERS Tag solution with 0.23mM AgNO 3 solution still maintains stable, however, big aggregations were observed in the solution with 1mM AgNO 3 ( Fig. S3 b and  c) . The concentration of Raman reporter molecular attached on the NPs is another principal factor which influences on the SERS intensity and stability of the SERS Tag. As shown in Fig.S3e , when the concentration of pATP was increased to 9.6mM, SERS intensity increased dramatically, but once the concentration exceeded 9.6mM, the intensity maintained at a same level or dropped slightly. Moreover when pATP concentration was 9.6mM, the solution with pATP concentration still maintain clear without aggregation. Based on these results, the optimized concentration of AgNO 3 and pATP were chosen as 0.23mM and 9.6mM respectively to achieve the highest Raman signal intensity and good stability of SERS Tag solution. 
Figure S7
The TEM images of exosomes from serum of patients with pancreatic cancer. Figure S8 The clinical values of CA19-9 and CEA in serum samples from patients with pancreatic cancer. Note: the red points represented the samples below the clinical reference value. In (d-a), (d-b) the green spots represented that the values was more than 1200 U/mL, while the blue one represented that the value was less than 2U/mL which was also the point that was below the clinical reference value.
We also investigated the clinical ELISA data of two standardized cancer markers, CEA and CA19-9, of these pancreatic cancer patients (n=22). The clinical reference value of CA19-9 was 37U/mL. For these 22 serum samples from pancreatic cancer patients, there were 7 cases below 37U/mL and 15 cases above 37U/mL ( Fig. S8-a,c) . The Mann-Whitney test for CA19-9 values (the results >1200U/mL was regarded as 1200U/mL, the results <2U/mL was regarded as 2U/mL) of "metastasis" and "infiltration not metastasis" groups showed that Z=-1.103, P=0.270, for PT3 and PT1~2 subgroups, the results showed that Z=-0.570, P=0.569 (Fig. 6C-b) . While for CEA, the clinical reference value was 5ng/mL, there were 13 cases below 5ng/mL and 9 cases above 5ng/mL ( Fig. S8-d, f) . The Mann-Whitney test for CEA values of "metastasis" and "infiltration not metastasis" groups showed that Z=-0.478, P=0.6333, for PT3 and PT1~2 subgroups, the results showed that Z=-0.566, P=0.571 (Fig.S8-e) . The results indicated that both CA19-9 and CEA had high false negative results and could not distinguish the two pairs of subgroups as MIF-exosome-SERS platform did. 
